Color Stock

color.comHealthcareFounded: 2014Funding to Date: $326.55MM

Color is the developer of a simple, affordable genetic test to help people understand their risk for hereditary cancer.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Color, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Othman Laraki
Co-founder, Chief Executive Officer & Board Member
Nish Bhat
Co-Founder
Wendy McKennon
Head, Product and Design

Board Members

Elad Gil Ph.D
Hemant Taneja
General Catalyst
Othman Laraki
Susan Wagner

Other companies like Color in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$453MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$263MM

News

Color's Othman Laraki thinks genetic testing will have its biggest impact on human health when we forget it's even there.
Officials heralded the opening of a mass vaccination site in Roxbury — the heart of Black life in Boston — but the residents who snagged the first appointments at the Reggie Lewis Track and Athletic Center Tuesday afternoon were overwhelmingly white.
Healthcare startup Color has raised a sizable $167 million in Series D funding round, at a valuation of $1.5 billion post-money, the company announced today. This brings the total raised by Color to $278 million, with its latest large round intended to help it build on a record year of growth in 20…